SCHEMBL7574729

SCHEMBL7574729

CC(=O)ONS(=O)(=O)c1ccc(N2CCC(c3ccccc3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 4/20 0.52
MMP13 P45452 4/20 0.52
MMP9 P14780 3/20 0.52
MMP3 P08254 1/20 0.50
SLC18A3 Q16572 3/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
MCOLN2 Q8IZK6 1/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
MCOLN1 Q9GZU1 1/20 0.42
USP5 P45974 2/20 0.41
MCHR1 Q99705 1/20 0.41
SFRP1 Q8N474 1/20 0.41
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4426623 0.79 MMP3 (0.54) MMP2MMP13MMP9MMP3USP5
SCHEMBL8343032 0.77 MMP2 (0.53) MMP2MMP13MMP9MMP3CA12
SCHEMBL6417993 0.77 MMP3 (0.52) MMP2MMP13MMP9MMP3USP5
SCHEMBL4434657 0.76 MMP2 (0.56) MMP2MMP13MMP9MMP3USP5
SCHEMBL6413210 0.75 MMP3 (0.65) MMP2MMP13MMP9MMP3
SCHEMBL6414008 0.75 MMP3 (0.65) MMP2MMP13MMP9MMP3
SCHEMBL6413216 0.75 MMP3 (0.65) MMP2MMP13MMP9MMP3
SCHEMBL2026104 0.75 BCAT1 (0.55) MMP2MMP13MMP9CA12CA1
SCHEMBL15801111 0.74 NPC1 (0.54) MMP2MMP13MMP9SLC18A3NPC1
SCHEMBL8343036 0.74 CA1 (0.63) MMP2MMP13MMP9MMP3CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0874836-B1 SULFONAMIDE INHIBITORS OF MATRIX METALLOPROTEINASES WARNER LAMBERT CO (US) 2002-10-09 EP disclosed
CN-1310629-A Combined administration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions WARNER LAMBERT CO (US) 2001-08-29 CN disclosed
US-6153612-A Sulfonamide inhibitors of matrix metalloproteinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US disclosed